microsomes (HLM) for the first time. After 60 mins of incubation, 5 potential metabolites of 23 TBECH were identified in microsomal assays of both the TBECH mixture and β-TBECH using 24 UPLC-Q-Exactive Orbitrap™ mass spectrometry. These include mono-and di-hydroxylated 25 TBECH, mono-and di-hydroxylated TriBECH as well as an α-oxidation metabolite bromo-(1,2-26 dibromocyclohexyl)-acetic acid. Our results indicate potential hepatic biotransformation of 27 TBECH via Cyctochrome P450-catalyzed hydroxylation, debromination and α-oxidation. Kinetic 28 studies revealed the formation of monohydroxy-TBECH, dihydroxy-TBECH and monohydroxy- 29 TriBECH were best fitted to a Michaelis-Menten enzyme kinetic model. Respective estimated 30 V max values (maximum metabolic rate) for these metabolites were: (11.8 ± 4), (0.6 ± 0.1) and 31 (10.1 ± 0.8) pmol/min/mg protein in TBECH mixture and (4992 ± 1340), (14.1 ± 4.9) and (66.1 ± 32 7.3) pmol/min/mg protein in β-TBECH. This indicates monohydroxy-TBECH as the major 33 metabolite of TBECH by human liver. The estimated intrinsic clearance (Cl int ) of TBECH mixture 34 was slower (P<0.05) than that of pure β-TBECH. While the formation of monohydroxy-TBECH 35 may reduce the bioaccumulation potential and provide a useful biomarker for monitoring 36 TBECH exposure, further studies are required to fully understand the levels and toxicological 37 implications of the identified metabolites.
Introduction 41 Brominated flame retardants (BFRs) are anthropogenic chemicals incorporated into materials also been banned in Europe and voluntarily phased out in the USA. These regulations have 48 paved the way for novel/emerging brominated flame retardants (NBFRs/EBFRs) introduced to 49 the market as replacements for PBDEs 1 . (n=92) samples from UK houses (mean = 173 pg/m 3 and 21.4 ng/g in air and dust) and offices (mean = 320 pg/m 3 and 41 ng/g in air and dust) 12 . TBECH also showed the highest levels of all 63 detected EFRs in Norwegian (mean = 209 pg/m 3 ) and Swedish (mean = 43 pg/m 3 ) indoor air 64 samples 5,6 indicating its wide application, especially in Europe. This is of concern due to its 65 potential toxicological effects on humans and wildlife. Several toxicological in silico, in vitro 66 (human and chicken cell lines) and in vivo (birds, fishes and rats) studies show TBECH is a strong 67 androgen receptor agonist and endocrine disruptor [13] [14] [15] [16] [17] [18] [19] [20] [21] . TBECH also displayed potential to 68 disrupt thyroid and sex hormones in American kestrels 20 , modulate thyroid axis in juvenile 69 Brown Trout 14 and alter androgen receptor regulation in human ductal breast cancer and 70 prostate cancer cell lines 21 . However, very little is known about the biotransformation and fate 71 of TBECH in humans. 72 Previous studies have shown some BFRs can be metabolized to more toxic lower brominated 73 congeners 23-25 . Two of the primary in vivo debrominated metabolites of decabromodiphenyl 74 ether (BDE-209) in rainbow trout were identified as BDE-47 and BDE-99 23 , which are more 75 bioaccumulative and showed much higher toxic potential than the parent compound in goldfish 76 and zebrafish liver cell lines 25, 26 . Similarly, hexabromocyclododecane (HBCD) was metabolized 77 by rat and trout liver S9 fractions into pentabromocyclododecenes (PBCDs), which showed 78 higher affinity for binding to the thyrotropin receptor (TSH) than the parent compound 24 . 79 Therefore, improved understanding of the biotransformation pathways, rates and products of 80 TBECH is essential for assessment of the risk arising from human exposure to this flame 81 retardant. 82 To our knowledge, only one study has investigated the potential metabolites of TBECH and 83 moreover used in vitro rat liver microsomes (RLM) 22 . Results revealed that after 60 min, 40% of 84 the exposure dose was metabolized by Cytochrome P450 enzymes into mono and dihydroxylated TBECH, together with some unidentified metabolites 22 . However, this study did 86 not provide information on the metabolic/hepatic clearance rate of TBECH. Moreover, 87 extrapolation of results from metabolic studies in rat to human is subject to uncertainty due to 88 inter-species variations in metabolic pathways and products. To illustrate, bioconversion from 89 α-, β-and γ-hexabromocyclododecane (HBCD) mixture into δ-HBCD was observed in trout but ii. m/z value of the molecular ion peak must be within 5 ppm of its theoretical value at 162 resolution power of 17500 FWHM (full width at half mass). 163 iii. Br isotope pattern must match within 5 % of the theoretically predicted abundances of 164 the predicted chemical formula. 165 iv. log 2 fold change (calculated as log 2 of the peak area ratio between in vitro samples and 166 experiment blanks) to be > 1. 167 Instrument blanks (10 µL methanol) were run before and after analysis of incubation (Figures 1a and 1b) . Similarly, peak M2-4 was identified as α-(OH) 2 -TBECH, 202 while peaks M2-5 and M2-6 originated from the β-isomer (Figures 1c and 1d) . 203 Our findings are generally in agreement with those reported using rat liver microsomes (RLM), 204 where two monohydroxy-and two dihydroxy-isomers were identified following exposure to 205 the TBECH technical mixture 22 . While the difference in the number of isomers in each 206 metabolite group may be attributed to inter-species variations, this hypothesis cannot be 207 confirmed in the absence of authentic metabolite standards.
208
Debrominated metabolites 209 In addition to the hydroxylated metabolites of the parent TBECH, we also identified 210 hydroxylated biotransformation products of debrominated TBECH with the formulae: C 8 216 and/or through debromination of parent TBECH followed by hydroxylation ( Figure 3) . This is 217 similar to previously reported in vitro metabolic pathways for hexabromocyclododecane 218 isomers (HBCDD) in rat 24 and human 29 , where both hydroxylation and debromination were 219 observed. 220 Interestingly, two separate peaks were identified for M3 following HLM exposure to technical 221 TBECH (Figure 2a ), while one peak (M3-7) was observed upon exposure to pure β-TBECH. 222 Therefore, peak M3-7 was assigned as β-OH-triBECH and peak M3-8 was attributed to α-OH-223 triBECH. We hypothesized that the observed M3 metabolites may be produced -at least 224 partially -from hydroxylation of a tribrominated metabolite (i.e. a tribromoethyl cyclohexane 225 derivative or triBECH) with a molecular formula of C 8 H 13 Br 3 . However, such triBECH metabolites 226 could not be detected in our samples even using the ultimate high separation and resolution 227 power of a GC x GC-ToF/MS platform in an independent analysis dedicated specifically to 228 identify this potential metabolite ( Figure SI-3) . Similar observations were reported in muscle 229 and liver samples of juvenile brown trout exposed to β-TBECH in their diet 30 , where no 230 debrominated metabolites were detected. While our experimental approach could not confirm 231 the formation of triBECH, the hypothesis cannot be refuted as triBECH might be produced then 232 transformed quickly to its hydroxylated metabolites (M3, Figure 2a ) before the reaction is 233 stopped after 60 min. 234 Four distinctive peaks of M4 (Figure 2c ) were detected when HLM were exposed to either 235 technical TBECH or pure β-TBECH. However, two additional peaks, designated as M4-13 and 236 M4-14 were observed upon exposure to pure β-TBECH only (Figure 2d ). Hence, M4-13 and M4-238 it was not possible to address the stereochemistry of peaks M4-9, M4-10, M4-11 and M4-12 239 (Figure 2c ). (Table 2) . Apparent V max values (maximum metabolic rate) 273 for the formation of monohydroxy-TBECH, dihydroxy TBECH and monohydroxy-TriBECH were 274 162.5, 0.64 and 10.1 pmol/min/mg protein, respectively (Table 2) 297 Where CL int is the apparent intrinsic in vitro hepatic clearance, CL int-liver is intrinsic in vitro 
CL h = (CL int-liver x Q h )/ (CL int-liver + Q h )…………………. (Equation 3)

